Anthralin

Anthralin

SCHEMBL17627910

COc1c2occc2cc2ccc(=O)oc12.O=C1c2c(O)cccc2Cc2cccc(O)c21

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.66
▸ MAOA P21397 3/20 0.66
▸ TSHR P16473 2/20 0.66
▸ PDE4A P27815 2/20 0.66
▸ CYP2A6 P11509 2/20 0.66
▸ CYP1A2 P05177 2/20 0.66
▸ MAPK1 P28482 2/20 0.66
▸ CYP2C19 P33261 2/20 0.66
▸ CYP2D6 P10635 1/20 0.66
▸ ACHE P22303 1/20 0.66
▸ SLC6A3 Q01959 1/20 0.66
▸ CYP2A13 Q16696 1/20 0.66
▸ KDM4E B2RXH2 6/20 0.52
▸ HSD17B10 Q99714 5/20 0.52
▸ MAPT P10636 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ ALDH1A1 P00352 7/20 0.47
▸ BACE1 P56817 2/20 0.47
▸ CYP1B1 Q16678 2/20 0.47
▸ ABCB1 P08183 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxsalen SCHEMBL2302069 0.81 CYP3A4 (1.00) CYP3A4MAOATSHRPDE4ACYP2A6
Methoxsalen SCHEMBL29376525 0.81 CYP3A4 (1.00) CYP3A4MAOATSHRPDE4ACYP2A6
Methoxsalen SCHEMBL19168 0.81 CYP3A4 (1.00) CYP3A4MAOATSHRPDE4ACYP2A6
Methoxsalen SCHEMBL6142553 0.80 CYP3A4 (0.97) CYP3A4MAOATSHRPDE4ACYP2A6
Methoxsalen SCHEMBL9387169 0.78 CYP3A4 (0.86) CYP3A4MAOATSHRPDE4ACYP2A6
Methoxsalen SCHEMBL10572509 0.77 CYP3A4 (0.84) CYP3A4MAOATSHRPDE4ACYP2A6
Methoxsalen SCHEMBL598765 0.73 CYP3A4 (0.82) CYP3A4MAOATSHRPDE4ACYP2A6
Bergapten SCHEMBL9792363 0.70 CYP3A4 (0.74) CYP3A4MAOATSHRPDE4ACYP2A6
Anthralin SCHEMBL30013383 0.68 MAPT (1.00) CYP3A4MAOATSHRPDE4AMAPK1
Anthralin SCHEMBL3197 0.68 MAPT (1.00) CYP3A4MAOATSHRPDE4AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016205659-A1 COMPOUND, COMPOSITION, POLYMER, MYLAR FILM AND METHOD FOR INDICATING MAXIMUM EXPOSURE TO THE SUN AND UV RADIATION SANDERS CLIFTON (US) 2016-12-22 — — WO disclosed
US-20160220454-A1 Compound, Composition, Polymer, Mylar Film and Method for Indicating Maximum Exposure to the Sun and UV Radiation GENESIS LABORATORIES INC (DE) 2016-08-04 — — US disclosed
US-20160089316-A1 Compound, Composition, Polymer, Mylar Film and Method for Indicating Maximum Exposure to the Sun and UV Radiation GENESIS LABORATORIES INC. (US) 2016-03-31 — — US disclosed
WO-2016048426-A1 COMPOUND, COMPOSITION, POLYMER, MYLAR FILM AND METHOD FOR INDICATING MAXIMUM EXPOSURE TO THE SUN AND UV RADIATION GENESIS LABORATORIES INC. (US) 2016-03-31 — — WO disclosed
Send feedback